Last year, we lost to (Archbishop) Ryan in the quarters to go to the Palestra
Subscribe to stay up to date with the latest news and tips GLP-1 medications present a substantial financial challenge for patients without insurance coverage, with monthly costs reaching $1,000
Clinical Evidence: Anxiety Risk on GLP-1 Receptor Agonists Major semaglutide trials, including STEP and SUSTAIN programs, reported anxiety in fewer than 3% of treatment participantsrates comparable to placebo control groups
Modern processes like fermentation or instant controlled pressure drop (ICD) increase mineral bioavailability and antioxidant capacity in amaranth-based products (Das et al., 2025
The effects run almost equally in both directions which tells you this is not a simple story
Patients are very comfortable with the close contact and care he establishes with each individual patient from initial consultation through surgery and beyond